CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Adding Imbruvica to CAR-T Cell Therapy May Improve CLL Outcomes

November 17th 2021, 10:00pm


Imbruvica plus Breyanzi, a CAR-T cell therapy, improved outcomes in patients with relapsed/refractory chronic lymphocytic leukemia, according to recent research.

CAR-T Cell Therapy Trial Currently Enrolling Patients With CLL and SLL

November 16th 2021, 12:00am


The TRANSCEND CLL 004 trial is currently enrolling patients to determine the efficacy of a CAR-T cell therapy.

‘Promising Times’ for Patients With CLL

October 16th 2021, 2:00pm


A fixed-duration treatment regimen may result in better outcomes and less time in the hospital for patients with CLL.

Survival May Be Possible for Patients With CLL Even With Small Amounts of Disease After Treatment

October 14th 2021, 1:00pm


Detectable amounts of minimal residual disease after treatment for CLL does not mean that all hope is lost for survival without disease progression.

WHO Adds Cancer and Smoking Cessation Medicines to Essential Drug List

October 6th 2021, 1:00pm


The World Health Organization updated their Model Lists of Essential Medicines to include more cancer treatments, though some popular cancer drugs were excluded from the list.

3 Things Cancer Survivors Need to Remember: From Someone Who Has Been There

October 4th 2021, 11:00pm


“Spending over a third of my life as a cancer survivor, I’ve learned a few lessons along the way,” said Lacey, who was diagnosed with chronic lymphocytic leukemia 13 years ago.

Which Mask Is Best for Protecting Patients With Cancer From a COVID-19 Variant?

September 27th 2021, 9:00pm


An expert explains virus mutations, the Delta variant of COVID-19 and which masks offer the best protection for patients with cancer.

Blood Cancer Survivors Should Not Rely on COVID-19 Antibody Tests to Determine Immunity

August 24th 2021, 1:00pm


Patients with blood cancers may be less likely to derive immunity from the COVID-19 vaccine, though antibody tests should not be the end-all-be-all in guiding their behavior.

BTK Inhibitors Are the Path Forward in Frontline CLL Treatment

August 19th 2021, 1:00pm


Patients with chronic lymphocytic leukemia should talk to their doctors about the use of BTK inhibitors, as they produced promising outcomes in multiple trials.

CLL Treatment Represents ‘Very Optimistic Area’ in Research

August 9th 2021, 9:00pm


Outcomes in patients with CLL continue to improve with the emergence of targeted drugs and immunotherapy.